Verona Pharma Plc - ADR

NASDAQ:VRNA   4:00:00 PM EDT
94.58
+0.76 (+0.81%)
7:21:35 PM EDT: $95.01 +0.43 (+0.46%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)8.05B
Current PEN/A
Forward PE 591.13
2yr Forward PE 87.57
See more stats
Estimates Current Quarter
Revenue$92.85 Million
Adjusted EPS$0.01
See more estimates
10-Day MA$93.72
50-Day MA$78.86
200-Day MA$55.16
See more pivots

Verona Pharma Plc - ADR Stock, NASDAQ:VRNA

3 More London Riverside, 3 More London Riverside, London, Greater London SE1 2RE
United Kingdom
Phone: +44.203.283.4200
Number of Employees: 209

Description

Verona Pharma Plc engages in the development and commercialization of therapeutics for the treatment of respiratory diseases. It focuses on developing inhaled ensifentrine for the maintenance treatment of chronic obstructive pulmonary disease. The company was founded by Michael J. A. Walker and Clive P. Page on February 24, 2005 and is headquartered in London, the United Kingdom.